Clinical Trials Browser

Unspecified Adult Solid Tumor, Protocol Specific

NCT00550901 2015-06-08

Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

25 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00423865 2015-05-25

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00415324 2014-05-20

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00046917 2014-02-24

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

13 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005791 2013-12-19

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005996 2013-12-19

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003108 2013-07-18

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00016874 2013-07-18

3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00024323 2013-07-18

Combination Chemotherapy in Treating Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004090 2013-07-10

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00012194 2013-07-09

7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors

Phase 1 Terminated

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003004 2013-06-24

Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors

Phase 1 Completed

73 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003242 2013-06-24

Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003742 2013-06-21

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00047047 2013-06-04

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

78 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00009932 2013-05-15

Combination Chemotherapy in Treating Patients With Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00084812 2013-03-22

Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

43 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006000 2013-01-31

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003132 2012-11-09

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004913 2012-06-01

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00573690 2012-04-24

Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors

Phase 1 Completed

31 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005819 2010-06-11

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

21 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006464 2010-01-15

UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004063 2009-04-30

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

Phase 1/2 Unknown

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer

Combination Chemotherapy in Treating Patients With Advanced Cancer

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors

Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors

Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Solid Tumors

Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer